About the Authors
- Sandra A. Springer
-
* E-mail: Sandra.springer@yale.edu
Affiliation Section of Infectious Disease, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, United States of America
- Jingjun Qiu
-
Affiliation Section of Infectious Disease, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, United States of America
- Ali Shabahang Saber-Tehrani
-
Affiliation Section of Infectious Disease, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, United States of America
- Frederick L. Altice
-
Affiliations Section of Infectious Disease, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, United States of America, Division of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, Connecticut, United States of America, The Faculty of Medicine, Centre of Excellence on Research in AIDS, University of Malaya, Kuala Lampur, Malaysia
Competing Interests
Buprenorprhine/naloxone was provided free of charge from Reckitt Benckiser through a contractual arrangement with the National Institutes on Drug Abuse. This does not alter the authors‘ adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SAS FLA. Performed the experiments: SAS. Analyzed the data: SAS JQ ASST FLA. Wrote the paper: SAS FLA.